Adapting Clinical Practice to a Rapidly Changing Therapeutic Landscape in Multiple Myeloma

In this comprehensive program centered on an in-person and online live CCO symposium at ASH 2021 experts discuss recent developments in management of multiple myeloma. Review their insights in clinical commentaries along with an on-demand webcast and downloadable slides from the symposium. In addition listen to the audio podcast to hear the experts answer audience questions and download a treatment algorithm to use in your clinic.

Share

Program Content

Activities

Adapting Practice in Myeloma
Adapting Clinical Practice to a Rapidly Changing Therapeutic Landscape in Multiple Myeloma
Multimedia
Congratulations: You achieved a completion on 04/09/2022

Released: January 27, 2022

Expires: January 26, 2023

Activities

Treating MM
Adapting to the Evolving Treatment Landscape for Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: December 07, 2021

Expires: December 06, 2022

Therapeutic Landscape in MM
Updates on the Rapidly Changing Therapeutic Landscape in Multiple Myeloma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 20, 2022

Expires: April 19, 2023

Activities

2022 MM Algorithm
Multiple Myeloma: Diagnosis and Treatment for 2022
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: January 31, 2022

Expires: January 30, 2023

Activities

Triple Class Refractory MM
Expert Guidance for Managing Triple Class–Refractory MM (Excluding BCMA-Targeted Therapies)
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2021

Expires: December 14, 2022

2022 MM Care Algorithm
Introduction to the 2022 MM Care Algorithm
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2021

Expires: December 14, 2022

BCMA-Targeted Tx for MM
Evolving Role for BCMA-Targeted Therapies for MM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2021

Expires: December 14, 2022

Smoldering MM
Evidence for Treating High-Risk Smoldering MM
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2021

Expires: December 14, 2022

ASCT-Eligible NDMM
Current Therapeutic Strategies for Newly Diagnosed MM That Are Eligible for ASCT
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2021

Expires: December 14, 2022

ASCT-Ineligible NDMM
Current Therapeutic Strategies for Newly Diagnosed MM That Are Ineligible for ASCT
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2021

Expires: December 14, 2022

MM at First Relapse
Tailoring Management for Patients With MM in First Relapse
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 15, 2021

Expires: December 14, 2022

EP: Therapeutic Landscape in Myeloma
ExpressPoints:
Adapting Clinical Practice to a Rapidly Changing Therapeutic Landscape in Multiple Myeloma
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: January 04, 2022

Expires: January 03, 2023

Activities

Myeloma: Patient Case Examples
Evolving Therapy for Myeloma: Experts Discuss Patient Case Examples
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: February 18, 2022

Expires: February 17, 2023

<i>Podcast Pearls</i>:Myeloma Patient Case Examples
Evolving Therapy for Myeloma: Experts Discuss Patient Case Examples
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: February 23, 2022

Expires: February 22, 2023

Faculty

cover img faculity

Brian G. M. Durie, MD

National Director, Hematologic Malignancies and Multiple Myeloma
Aptium Oncology, Inc.
Co-Chair, Myeloma Committee – SWOG
Chairman, International Myeloma Foundation
Specialist, Multiple Myeloma and Related Disorders
Cedars-Sinai Outpatient Cancer Center
Los Angeles, California

cover img faculity

David Gilden

Contributing Editor

cover img faculity

Brian Hoyle

Contributing Editor

cover img faculity

Thomas G. Martin, MD

Associate Clinical Professor of Medicine
Associate Director
, Myeloma Institute
University of California, San Francisco Medical Center
San Francisco, California

cover img faculity

Vincent A. Miller, MD

Associate Attending Physician
Thoracic Oncology Service
Memorial Sloan-Kettering Cancer Center
New York, New York

cover img faculity

Philippe Moreau, MD

Professor of Clinical Hematology
University Hospital of Nantes
Nantes, France

cover img faculity

S. Vincent Rajkumar, MD

Professor of Medicine
Chair, Myeloma Amyloidosis Dysproteinemia Group
Mayo Clinic
Rochester, Minnesota

cover img faculity

Jesus San-Miguel, MD, PhD

Director of Clinical and Translational Medicine
Clinica Universidad de Navarra
Universidad de Navarra
Pamplona, Spain

cover img faculity

Jesús F. San-Miguel, MD, PhD

Head, Hematology Department
Professor of Medicine
Hospital Universitario de Salamanca and Centro de Investigación del Cáncer
University of Salamanca
Salamanca, Spain

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Bristol Myers Squibb

Genentech, a member of the Roche Group

GlaxoSmithKline

Janssen administered by Scientific Affairs

Karyopharm Therapeutics

Oncopeptides

Pfizer, Inc.

Sanofi Genzyme

Partners

International Myeloma Foundation

ProCE Banner